Statistics for Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod
Total visits
| views | |
|---|---|
| Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod | 0 |
Total visits per month
| views | |
|---|---|
| October 2023 | 0 |
| November 2023 | 0 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
File Visits
| views | |
|---|---|
| Clinical implications for substandard, nonproprietary medicines in multiple sclerosis Focus on fingolimod.pdf | 2 |